Trinity Biotech ( (TRIB) ) has provided an announcement.
Trinity Biotech announced on April 4, 2025, the appointment of Susan O’Connor as Interim CFO, succeeding Louise Tallon, effective April 11, 2025. The company clarified that Tallon’s departure was not due to any disagreements with the company, and this leadership change is expected to maintain operational stability.
More about Trinity Biotech
Trinity Biotech plc is a commercial-stage biotechnology company based in Ireland, specializing in human diagnostics and diabetes management solutions, including wearable biosensors.
YTD Price Performance: -40.0%
Average Trading Volume: 2,141,559
Technical Sentiment Signal: Strong Buy
Current Market Cap: $6.48M
For detailed information about TRIB stock, go to TipRanks’ Stock Analysis page.